Literature DB >> 20501683

Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.

Paul Kuo1, Judith M Wishart, Max Bellon, André J Smout, Richard H Holloway, Robert J L Fraser, Michael Horowitz, Karen L Jones, Christopher K Rayner.   

Abstract

CONTEXT: Acute hyperglycemia slows gastric emptying, but its effects on small intestinal motor activity and glucose absorption are unknown. In type 2 diabetes, the postprandial secretion of glucose-dependent insulinotropic polypeptide (GIP) is preserved, but that of glucagon-like peptide-1 (GLP-1) is possibly reduced; whether the latter is secondary to hyperglycemia or diabetes per se is unknown. AIM: The aim was to investigate the effects of acute hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin hormone secretion.
METHODS: Nine healthy volunteers were studied on two occasions. A combined manometry/impedance catheter was positioned in the duodenum. Blood glucose was clamped at either 9 mmol/liter (hyperglycemia) or 5 mmol/liter (euglycemia) throughout the study. Manometry and impedance recordings continued between T=-10 min and T=180 min. Between T=0 and 60 min, an intraduodenal glucose infusion was given (approximately 3 kcal/min), together with 14C-labeled 3-O-methylglucose (3-OMG) to evaluate glucose absorption.
RESULTS: Hyperglycemia had no effect on duodenal pressure waves or flow events during the 60 min of intraduodenal glucose infusion, when compared to euglycemia. During hyperglycemia, there was an increase in plasma GIP (P<0.05) and 14C-3-OMG (P<0.05) but no effect on GLP-1 concentrations in response to the intraduodenal infusion, compared to euglycemia.
CONCLUSION: Acute hyperglycemia in the physiological range has no effect on duodenal pressure waves and flow events but is associated with increased GIP secretion and rate of glucose absorption in response to intraduodenal glucose.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501683     DOI: 10.1210/jc.2009-2514

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  6 in total

1.  Modulation of individual components of gastric motor response to duodenal glucose.

Authors:  Adam M Deane; Laura K Besanko; Carly M Burgstad; Marianne J Chapman; Michael Horowitz; Robert J L Fraser
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

Review 2.  An ANMS-NASPGHAN consensus document on esophageal and antroduodenal manometry in children.

Authors:  R Rosen; J M Garza; N Tipnis; S Nurko
Journal:  Neurogastroenterol Motil       Date:  2017-11-27       Impact factor: 3.598

3.  Mesenteric blood flow, glucose absorption and blood pressure responses to small intestinal glucose in critically ill patients older than 65 years.

Authors:  Jennifer A Sim; M Horowitz; M J Summers; L G Trahair; R S Goud; A V Zaknic; T Hausken; J D Fraser; M J Chapman; K L Jones; A M Deane
Journal:  Intensive Care Med       Date:  2012-10-25       Impact factor: 17.440

4.  Decision support for optimized blood glucose control and nutrition in a neurotrauma intensive care unit: preliminary results of clinical advice and prediction accuracy of the Glucosafe system.

Authors:  Ulrike Pielmeier; Mark Lillelund Rousing; Steen Andreassen; Birgitte Steenfeldt Nielsen; Pernille Haure
Journal:  J Clin Monit Comput       Date:  2012-05-13       Impact factor: 2.502

5.  Comparative effects on glucose absorption of intragastric and post-pyloric nutrient delivery in the critically ill.

Authors:  Anna E Di Bartolomeo; Marianne J Chapman; Antony V Zaknic; Matthew J Summers; Karen L Jones; Nam Q Nguyen; Christopher K Rayner; Michael Horowitz; Adam M Deane
Journal:  Crit Care       Date:  2012-09-17       Impact factor: 9.097

6.  Disordered control of intestinal sweet taste receptor expression and glucose absorption in type 2 diabetes.

Authors:  Richard L Young; Bridgette Chia; Nicole J Isaacs; Jing Ma; Joan Khoo; Tongzhi Wu; Michael Horowitz; Christopher K Rayner
Journal:  Diabetes       Date:  2013-06-12       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.